If additional glycemic control is needed after at least 4 weeks on the 0.5 mg dosage, the dosage may be increased to 1 mg once weekly
However, more preclinical and clinical cohort studies are needed to determine QUEs efficacy, mechanism, optimal formulation, and long-term effects in synergistic chemotherapy and immunomodulatory effects
Retinal conditions require systemic administration (injection) accepting barrier penetration limitations
2a) but increased AST and ALT levels in ALT non-responders (Fig
The drug is approved for people who are overweight or obese and have at least one weight-related health issue, such as high blood pressure or heart or kidney issues
Inject the water slowly down the inside wall of the vial, gently swirl until dissolved, and refrigerate at 36-46F